Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have rectal cancer (a specific type called adenocarcinoma) and have completed a course of chemotherapy combined with radiation therapy, with follow-up scans showing no signs of remaining cancer
- People whose overall physical health falls within a standard fitness range considered acceptable for surgery (confirmed by a doctor's assessment)
- People whose tumour is located close enough to the opening of the bowel that it can be removed through a procedure performed via the back passage — generally within about 6 cm of the anal opening
- People aged between 18 and 75 years old
Who may not be able to join:
- People whose blood test for circulating tumour DNA (a marker found in the bloodstream) shows signs that cancer may still be present
- People with a Body Mass Index (BMI) above 40 (a measure of body weight relative to height)
- People who have had a previous surgery on the abdomen or pelvis
- People who have abnormal liver, kidney, or blood test results after completing their chemotherapy and radiation treatment (confirm specific values with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jin-Tung LIANG, MD, National Taiwan University Hospital
Phone: +886-972654554
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.